Inventor
WOLL MATTHEW G
US15 patents
⚠️ This page may combine multiple inventors who share the name “WOLL MATTHEW G”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
PTC THERAPEUTICS INC
13 patentsUS9879007B2Jan 30, 2018
Compounds for treating spinal muscular atrophy
PTC THERAPEUTICS INC18 citations93
US9617268B2Apr 11, 2017
Compounds for treating spinal muscular atrophy
PTC THERAPEUTICS INC32 citations93
US9586955B2Mar 7, 2017
Compounds for treating spinal muscular atrophy
PTC THERAPEUTICS INC22 citations93
US11753407B2Sep 12, 2023
Compounds for treating spinal muscular atrophy
PTC THERAPEUTICS INC0 citations61
US12384789B2Aug 12, 2025
Compounds for treating Huntington's disease
PTC THERAPEUTICS INC0 citations59
US11407753B2Aug 9, 2022
Compounds for treating Huntington's disease
PTC THERAPEUTICS INC0 citations59
US11780839B2Oct 10, 2023
Compounds for treating Huntington's disease
PTC THERAPEUTICS INC0 citations56
US10851101B2Dec 1, 2020
Compounds for treating spinal muscular atrophy
PTC THERAPEUTICS INC0 citations51
USRE47689ENov 5, 2019
Compounds for treating spinal muscular atrophy
PTC THERAPEUTICS INC0 citations51
US12139499B2Nov 12, 2024
Heteroaryl compounds for treating Huntington's disease
PTC THERAPEUTICS INC0 citations49
US11858941B2Jan 2, 2024
Heterocyclic and heteroaryl compounds for treating Huntington's disease
PTC THERAPEUTICS INC0 citations49
US11382918B2Jul 12, 2022
Methods for treating Huntington's Disease
PTC THERAPEUTICS INC0 citations48
US12577226B2Mar 17, 2026
Compounds for treating Huntington's disease
PTC THERAPEUTICS INC0 citations46